#DarkBlueTherapeutics
In what is thought to be the first major pharma #M&A deal of the year, #Amgen has bought Oxford, UK-based #biotech #DarkBlueTherapeutics (DBT), which specialises in #cancer therapies.

pharmaphorum.com/news/amgen-i...
Amgen inks $840m takeover of UK's Dark Blue Therapeutics
Amgen has added a new acute myeloid leukaemia drug with the takeover of Dark Blue Therapeutics and its first-in-class MLLT 1/3 degrader.
pharmaphorum.com
January 6, 2026 at 6:00 PM